$Abivax(ABVX)$ 跟踪过很久的公司。过山车式🎢。UC新药终于有了好催化剂。暴涨。ABVX shares are halted following results that its 50mg obefazimod achieved 16.4% pooled placebo-adjusted clinical remission at 8 weeks in Phase 3 ABTECT induction trials for moderate-to-severe UC,

$Abivax(ABVX)$ 跟踪过很久的公司。过山车式🎢。UC新药终于有了好催化剂。暴涨。

ABVX shares are halted following results that its 50mg obefazimod achieved 16.4% pooled placebo-adjusted clinical remission at 8 weeks in Phase 3 ABTECT induction trials for moderate-to-severe UC, meeting all key secondary endpoints with favorable safety. Maintenance data is due 2Q 2026, ahead of planned NDA/MAA submissions in 2H 2026.

发布于上海